跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Lenalid 25 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Lenalid 25
Approved
STANDARD
Lenalid 25
Natco Pharma Limited Pharma Division (Unit IV and V)
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
d37ab9e65a43c971
Company
Natco Pharma Limited Pharma Division (Unit IV and V)
Type
Standard
Approval Details
Approval Id
d37ab9e65a43c971
Drug Approval Philippines Name
Lenalid 25
Product Name
Lenalid 25
Registration Number
DR-XY48666
Brand Name
Lenalid 25
Generic Name
Lenalidomide
Dosage Form
Capsule
Dosage Strength
25 mg
Manufacturer
Natco Pharma Limited Pharma Division (Unit IV and V)
Importer
Natco Lifesciences Philippines, Inc.
Distributor
Natco Lifesciences Philippines, Inc.
Issuance Date
27 March 2023
Expiry Date
27 March 2028
Pharmacologic Category
Immunosuppressant
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
d37ab9e65a43c971
Type
Standard
Back to Philippines FDA Approvals